These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32103895)

  • 1. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats.
    Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D
    Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
    Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
    J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Tang-Shen-Ning decoction on podocyte epithelial-esenchymal transformation via inhibiting Wnt/β-catenin pathway in diabetic mice.
    Cui FQ; Gao YB; Wang YF; Meng Y; Cai Z; Shen C; Jiang XC; Zhao WJ
    Ann Palliat Med; 2021 Dec; 10(12):12921-12936. PubMed ID: 32921066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation].
    Shi G; Wu W; Wan YG; Hex HW; Tu Y; Han WB; Liu BH; Liu YL; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):139-146. PubMed ID: 29552824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.
    Li J; Qiu P; Wang S; Wu J; He Q; Li K; Xu L
    Biomed Pharmacother; 2019 Jun; 114():108801. PubMed ID: 30928803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease.
    Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X
    Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
    Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy.
    Alomari G; Al-Trad B; Hamdan S; Aljabali A; Al-Zoubi M; Bataineh N; Qar J; Tambuwala MM
    Drug Deliv Transl Res; 2020 Feb; 10(1):216-226. PubMed ID: 31637677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
    Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
    Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
    J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.
    Tu Q; Li Y; Jin J; Jiang X; Ren Y; He Q
    Pharm Biol; 2019 Dec; 57(1):778-786. PubMed ID: 31741405
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats through Modulating PTEN-PDK1-Akt-mTOR Pathway.
    Xue R; Zhai R; Xie L; Zheng Z; Jian G; Chen T; Su J; Gao C; Wang N; Yang X; Xu Y; Gui D
    J Diabetes Res; 2020; 2020():9309768. PubMed ID: 32051833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.